A Study of LY2940680 in Japanese Participants With Advanced Cancers

Clinical trial NCT01919398 · COMPLETED

Trial details

NCT number: NCT01919398
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Metastasis

Start date: 2013-08-01
Primary completion: 2016-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.